Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Pharmacol Res. 2021 Nov 8;174:105973. doi: 10.1016/j.phrs.2021.105973

Table 3.

Summary of mRNA fold changes in mutant Tau-HT22 cells relative control HT22 cells and mitophagy enhancers treated in mutant Tau-HT22 treated cells relative to mutant Tau-HT22 untreated cells


Genes
mRNA fold change in mTau HT22 cells mRNA fold change in nicotinamide riboside treated mTau mRNA fold change in tomatidine treated mTau mRNA fold change in urolithin A treated mTau mRNA fold change in actinonin treated mTau
Mitochondrial structural genes Drp1 2.44*** −1.38 −1.61* −2.22** −2.04*
Fis1 1.57** −1.33 −1.31* −1.78** −1.19
Mfn1 −1.81* 1.36 1.96** 2.75*** 1.18
Mfn2 −1.53 2.32*** 2.44*** 5.32**** 1.52**
OPA1 −2.77* 1.97* 1.63 2.89** 1.66*
Biogenesis genes PGC1α −1.44 1.65 1.74 2.2* 1.35
Nrf1 −2.43* 1.75* 1.57* 2.51*** 1.43*
Nrf2 −1.33 1.17 1.36* 1.7* 1.1
TFAM −3.03 7.09**** 8.15**** 9.58**** 1.35
Synaptic genes Mitophagy genes Synaptophysin −1.47 3.81 8.44**** 9.54**** 4.05
PINK1 −2.38 6.69**** 3.77*** 7.53**** 3.05
Parkin −1.45 3.4 2.9* 3.89** 2.64*